About this episode

The episode reviews Q2 2026 earnings, highlighting significant profit changes and stock performance in the JSE market.

Carreras just posted an 80% profit surge and a $30 share price, but is a buyout next? Dr. Matthew Preston and Dr. Thaon Simms break down what's really driving the numbers, plus seven more JSE stocks worth watching this quarter. From Fesco's record fuel profits to Tropical Battery's failed capital raise, Omni's hurricane fueled growth, and why Elite Diagnostic just hit a fresh 52 week low. If you're holding JSE stocks, this recap tells you what actually matters. Chapters: 00:00 Introduction ...

People in this episode

Hosts: Dr. Matthew Preston, Dr. Thaon Simms

Topics covered

• earnings review
• JSE stocks
• profit surge
• buyout speculation
• market analysis
• investment opportunities

Keywords

• earnings season
• profit surge
• JSE stocks
• market analysis
• investment

Mentioned in this episode

Organizations: Carreras, Fesco, Tropical Battery, Omni, Elite Diagnostic

More episodes of Limitless

• DERRIMON'S $3.77 BILLION WRITE OFF: 28 Years of Profit ERASED · July 17, 2026 · 1h 6m
• The Ex JPS CEO Betting Everything On A $60 Million Solar Farm · July 10, 2026 · 1h 10m
• Building a $1 Million JSE Portfolio From Scratch in 2026 · June 26, 2026 · 57 min
• Why Scotiabank Delisting May Be The Worst Thing For The JSE · June 19, 2026 · 50 min

Explore listener stats, chart rankings, contacts and more on the Limitless podcast page.